Due in large measure to COVID-19-related concerns about the safety of participants and research staff, IRB reviews and decisions are often taking longer than they did pre-pandemic. IRBs are reviewing some studies they would not have reviewed in the past, contributing to delays. If a study is deemed to pose a significant risk of COVID-19 exposure without offering any benefit to participating subjects, the IRB may elect to not approve the study. The Human Subjects Office asks for researchers’ patience and cooperation as everyone strives to ensure that safety is first and foremost. For more information, contact HSO at email@example.com or 706-542-3199.